Related Experiment Video
Updated: Apr 19, 2026
07:59
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
1.9K
Hajdu-Cheney syndrome: a review
Ernesto Canalis1, Stefano Zanotti2
1Departments of Orthopaedic Surgery and Medicine, UConn Health, 263 Farmington Avenue, Farmington, CT 06030, USA. canalis@uchc.edu.
Orphanet Journal of Rare Diseases
|December 11, 2014
Summary
Hajdu Cheney Syndrome (HCS) is a rare genetic disorder caused by NOTCH2 gene mutations. These mutations lead to enhanced NOTCH2 signaling, impacting skeletal development and causing bone abnormalities.
Area of Science:
- Genetics
- Skeletal Biology
- Rare Diseases
Background:
- Hajdu Cheney Syndrome (HCS) is a rare autosomal dominant disorder.
- HCS presents with acroosteolysis, osteoporosis, short stature, craniofacial anomalies, and other systemic defects.
- The genetic basis of HCS involves mutations in the NOTCH2 gene.
Purpose of the Study:
- To investigate the role of NOTCH2 mutations in HCS.
- To understand the molecular mechanisms underlying HCS pathogenesis.
- To establish diagnostic approaches for HCS.
Main Methods:
- Sequence analysis of exon 34 of the NOTCH2 gene.
- Analysis of NOTCH2 protein stability and signaling activity.
- Review of clinical and genetic data from HCS patients.
Main Results:
- HCS is associated with specific mutations in exon 34 of NOTCH2, upstream the PEST domain.
- These mutations result in a truncated, stable NOTCH2 protein with enhanced signaling.
- Sequence analysis of NOTCH2 exon 34 is a viable diagnostic method for HCS.
Conclusions:
- Gain-of-function mutations in NOTCH2 are causative for HCS.
- NOTCH2 signaling dysregulation significantly impacts skeletal development and homeostasis.
- Further research is needed to elucidate bone loss mechanisms and establish effective therapies for HCS.
Related Concept Videos
01:19Cushing Syndrome II: Pathophysiology
1
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
1
01:26Cushing Syndrome I: Introduction
13
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
13
01:21Huntington Disease l: Introduction
11
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
11
01:21Chronic Pancreatitis II: Pathophysiology
17
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
17
01:29Chronic Pancreatitis II: Collaborative Care
541
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
541
01:25Chronic Pancreatitis I: Introduction
17
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
17